GP leads battle against COPD

December 2004
Pulse;12/20/2004, Vol. 64 Issue 50, p4
The article reports that Noel O'Kelly, a GP in Spilsby, Lincolnshire, has cut emergency chronic obstructive pulmonary disease admissions by a quarter after spearheading a local scheme to target the disease.


Related Articles

  • Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone. Löfdahl, Claes-Göran; Ericsson, Å; Svensson, Klas; Andreasson, Emma; Löfdahl, Claes-Göran; Ericsson, Asa // PharmacoEconomics;2005, Vol. 23 Issue 4, p365 

    Objective: To compare the healthcare costs and effects of budesonide/formoterol in a single inhaler with those of budesonide and formoterol monotherapies, and placebo, in a multinational study in patients with chronic obstructive pulmonary disease (COPD), National Heart, Lung and...

  • Cost Effectiveness of Pharmacological Maintenance Treatment for Chronic Obstructive Pulmonary Disease A Review of the Evidence and Methodological Issues. Rutten-van Mölken, Maureen P.M.H; Goossens, Lucas M.A. // PharmacoEconomics;2012, Vol. 30 Issue 4, p271 

    Background: Over 200 million people have chronic obstructive pulmonary disease (COPD) worldwide. The number of disease-year equivalents and deaths attributable to COPD are high.Guidelines for the pharmacological treatment of the disease recommend an individualized step-up approach in which...

  • Cost-effectiveness of conservative treatments for neck pain: a systematic review on economic evaluations. Driessen, Maurice; Lin, Chung-Wei; Tulder, Maurits // European Spine Journal;Aug2012, Vol. 21 Issue 8, p1441 

    Purpose: Various conservative interventions have been used for the treatment of non-specific neck pain. The aim of this systematic review was to investigate the cost-effectiveness of conservative treatments for non-specific neck pain. Methods: Clinical and economic electronic databases,...

  • Allergic rhinitis: evidence for impact on asthma. Thomas, Mike // BMC Pulmonary Medicine;2006 Supplement 1, Vol. 6, pS4 

    Background: This paper reviews the current evidence indicating that comorbid allergic rhinitis may have clinically relevant effects on asthma. Discussion: Allergic rhinitis is very common in patients with asthma, with a reported prevalence of up to 100% in those with allergic asthma. While the...

  • New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses. Mapel, Douglas W.; Roberts, Melissa H. // PharmacoEconomics;2012, Vol. 30 Issue 10, p869 

    Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death and disability worldwide, but before the development of several new pharmacological treatments little could be done for COPD patients. Recognition that these new treatments could significantly improve the...

  • New treatments in pipeline may prompt breakout year in murky COPD waterfront. Johnsen, Michael // Drug Store News;1/19/2004, Vol. 26 Issue 1, p21 

    Predicts the breakout of chronic obstructive pulmonary disease (COPD) in the U.S. in 2004. Absence of standardized treatment for the disease; Efforts of the U.S. COPD Coalitions to raise awareness among general practitioners; Association of the disease to smoking.

  • Is the BTS/SIGN guideline confusing? A retrospective database analysis of asthma therapy. Covvey, Jordan R.; Johnston, Blair F.; Wood, Fraser; Boyter, Anne C. // Primary Care Respiratory Journal;Sep2013, Vol. 22 Issue 3, p290 

    Background: The British guideline on the management of asthma produced by the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) describes five steps for the management of chronic asthma. Combination therapy of a long- acting 32-agonist (LABA) and an...

  • Doubt over COPD case-finding plan. Praities, Nigel // Pulse;10/21/2009, Vol. 69 Issue 33, p13 

    The article discusses the result of the study which reveals that chronic obstructive pulmonary disease (COPD) screening in practices is not as effective as going to public places in Great Britain. Lead researcher Richard Gilbert says that holding public events and screening smokers with symptoms...

  • For hospitals, a model to stabilize spiking costs. Caliendo, Melinda // njbiz;7/16/2012, Vol. 25 Issue 29, p5 

    The article explains the role of unit of care model in managing healthcare costs in New Jersey. The model focused on applying treatment costs in computing for healthcare reimbursements from the state government, where the treatment costs include revenues of doctors and solutions used for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics